کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
5821581 1557809 2016 8 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
New insights into the interaction between pyrrolyl diketoacids and HIV-1 integrase active site and comparison with RNase H
موضوعات مرتبط
علوم زیستی و بیوفناوری ایمنی شناسی و میکروب شناسی ویروس شناسی
پیش نمایش صفحه اول مقاله
New insights into the interaction between pyrrolyl diketoacids and HIV-1 integrase active site and comparison with RNase H
چکیده انگلیسی


- Pyrrolyl DKA scaffold interacts with P145, Q146 and Q148 HIV-1 IN residues.
- Pyrrolyl DKAs retain activity against HIV-1 RAL resistant Y143A and N155H INs.
- RDS1611 blocks HIV-1 replication inhibiting both RT and IN in cell-based assays.

HIV-1 integrase (IN) inhibitors are one of the most recent innovations in the treatment of HIV infection. The selection of drug resistance viral strains is however a still open issue requiring constant efforts to identify new anti-HIV-1 drugs. Pyrrolyl diketo acid (DKA) derivatives inhibit HIV-1 replication by interacting with the Mg2+ cofactors within the HIV-1 IN active site or within the HIV-1 reverse-transcriptase associated ribonuclease H (RNase H) active site. While the interaction mode of pyrrolyl DKAs with the RNase H active site has been recently reported and substantiated by mutagenesis experiments, their interaction within the IN active site still lacks a detailed understanding. In this study, we investigated the binding mode of four pyrrolyl DKAs to the HIV-1 IN active site by molecular modeling coupled with site-directed mutagenesis studies showing that the DKA pyrrolyl scaffold primarily interacts with the IN amino residues P145, Q146 and Q148. Importantly, the tested DKAs demonstrated good effectiveness against HIV-1 Raltegravir resistant Y143A and N155H INs, thus showing an interaction pattern with relevant differences if compared with the first generation IN inhibitors. These data provide precious insights for the design of new HIV inhibitors active on clinically selected Raltegravir resistant variants. Furthermore, this study provides new structural information to modulate IN and RNase H inhibitory activities for development of dual-acting anti-HIV agents.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Antiviral Research - Volume 134, October 2016, Pages 236-243
نویسندگان
, , , , , , , , , , , , ,